Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.863 3 days ( 4.04 % )
Last Price $6.41 -4.75 %
High/ Low $6.38 - $6.95 3.76%
Chg 7 Days -7.77 % $6.95 $6.41
Chg 30 Days -7.90 % $6.96 $6.41
Chg 12 mos -65.80 % $18.74 $6.41
Trend - 3 mos -22.46 % Width: 57.02 %
Trend - 12 mos -78.12 % Width: 476.00 %
Pred. range - 3 mos $3.70 - $5.81 -42.30 % - -9.39 %
Pred. range - 12 mos N/A - $1.16 -100.00 % - -81.86 %
Short MA avg 3 mos Sell May 07, 2024 - 4 days
Long MA avg 3 mos Sell Mar 22, 2024 - 35 days
Short/Long MA avg 3 mos Sell Mar 25, 2024 - 34 days
Short MA avg 12 mos Sell May 07, 2024 - 4 days
Long MA avg 12 mos Sell Aug 31, 2023 - 175 days
Short/Long MA avg 12 mos Sell Aug 21, 2023 - 183 days
Pivot Short Sell May 06, 2024 - 5 days
Bollinger Buy Apr 02, 2024 - 29 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Replimune Group Inc.

Replimune Group. Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Pha... REPL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT